Caroline Dive

Caroline Dive, Lee Lancashire, Robert Sloane, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Statistical Considerations of Optimal Study Design for Human Plasma Proteomics and Biomarker Discovery

Caroline Dive, Michael J. Walker, Anthony D. Whetton, 2012, Journal of proteome research.

Molecular analysis of circulating tumour cells—biology and biomarkers

Caroline Dive, Ged Brady, C. Dive, 2014, Nature Reviews Clinical Oncology.

Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Ashwini Naik, Allan Hackshaw, Zoltan Szallasi, 2017, Nature.

Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.

Caroline Dive, Lee Lancashire, Robert Sloane, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative mass spectrometry-based techniques for clinical use: Biomarker identification and quantification

Caroline Dive, Anthony D. Whetton, A. Whetton, 2008, Journal of Chromatography B.

1628O Development of the Manchester Cancer Research Centre Molecular Tumour Board for matching patients to clinical trials based on tumour and ctDNA genetic profiling.

Mahmood Ayub, Caroline Dive, Ged Brady, 2017 .

Somatically mutated ABL1 is an actionable and essential NSCLC survival gene

Caroline Dive, J. Brognard, P. Torres-Ayuso, 2016, EMBO molecular medicine.

Progress and prospects of early detection in lung cancer

Caroline Dive, C. Dive, Jakub Chudziak, 2017, Open Biology.

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer

Caroline Dive, Andrew Hughes, M. Ranson, 2007, Biomarker insights.

Circulating tumour cells: their utility in cancer management and predicting outcomes

Caroline Dive, T. Ward, C. Dive, 2010, Therapeutic advances in medical oncology.

Tumorigenesis and Neoplastic Progression Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Caroline Dive, Lee Lancashire, Andrew Hughes, 2010 .

Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models

Marek Dynowski, Caroline Dive, Ged Brady, 2017, Molecular Cancer Research.

Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study

Mark Cobbold, Iftekhar Khan, Caroline Dive, 2014, PLoS biology.

Circulating tumor cells as a window on metastasis biology in lung cancer.

Caroline Dive, Robert Sloane, Andrew Hughes, 2011, The American journal of pathology.

Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

Caroline Dive, Lee Lancashire, Robert Sloane, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer

Peter Schmid, Marcin Skrzypski, Allan Hackshaw, 2019, Nature Medicine.

Application of the β-expectation tolerance interval to method validation of the M30 and M65 ELISA cell death biomarker assays.

Jeffrey Cummings, Caroline Dive, C. Dive, 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

Caroline Dive, Claire Cole, Gordon C Jayson, 2010, Cancer biology & therapy.

Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells

Mahmood Ayub, Dominic G Rothwell, Caroline Dive, 2014, BMC Genomics.